Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Existing Antiviral Options Against SARS-CoV-2 Replication in COVID-19 Patients

1 Dec 2020

Abstract excerpt

COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing broad-spectrum antiviral drugs could be an effective strategy to respond immediately. In this review, a number of...

Topics

Join the communities discussing this publication.

COVID-19 Clinical Research Studies
SARS-CoV-2 and COVID-19 Research
Viral gastroenteritis research and epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33404263
DOI: 10.2217/fmb-2020-0120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Existing Antiviral Options Against SARS-CoV-2 Replication in COVID-19 PatientsPMID 33404263Read ↗

Minireview of progress in the structural study of SARS-CoV-2 proteinsSemantic proximity Read ↗

Recent advances in small-molecular therapeutics for COVID-19Semantic proximity Read ↗

Anti-viral chimeric protein RetroMAD1™ potently block SARS-CoV-2 viral entry and propagationSemantic proximity Read ↗

Druggable targets and therapeutic development for COVID-19Semantic proximity Read ↗

Novel coronavirus disease (COVID-19) pandemic: A recent mini reviewSemantic proximity Read ↗

Antivirals and Biologics for Broader Coverage Against Human CoronavirusesSemantic proximity Read ↗

TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)Semantic proximity Read ↗

The recent outbreaks of human coronaviruses: A medicinal chemistry perspectiveSemantic proximity Read ↗

A comprehensive review on the global efforts on vaccines and repurposed drugs for combating COVID-19Semantic proximity Read ↗

Structural biology of SARS-CoV-2: open the door for novel therapiesSemantic proximity Read ↗

A Comprehensive Overview of the Newly Emerged COVID-19 Pandemic: Features, Origin, Genomics, Epidemiology, Treatment, and PreventionSemantic proximity Read ↗

SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.